EP1109911A4 - Genes de staphylococcus aureus et polypeptides associes - Google Patents

Genes de staphylococcus aureus et polypeptides associes

Info

Publication number
EP1109911A4
EP1109911A4 EP99948076A EP99948076A EP1109911A4 EP 1109911 A4 EP1109911 A4 EP 1109911A4 EP 99948076 A EP99948076 A EP 99948076A EP 99948076 A EP99948076 A EP 99948076A EP 1109911 A4 EP1109911 A4 EP 1109911A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
staphylococcus aureus
aureus genes
genes
staphylococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99948076A
Other languages
German (de)
English (en)
Other versions
EP1109911A2 (fr
Inventor
Camella C Bailey
Gil H Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1109911A2 publication Critical patent/EP1109911A2/fr
Publication of EP1109911A4 publication Critical patent/EP1109911A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP99948076A 1998-09-01 1999-08-31 Genes de staphylococcus aureus et polypeptides associes Withdrawn EP1109911A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9896498P 1998-09-01 1998-09-01
US98964P 1998-09-01
PCT/US1999/019726 WO2000012678A2 (fr) 1998-09-01 1999-08-31 Genes de staphylococcus aureus et polypeptides associes

Publications (2)

Publication Number Publication Date
EP1109911A2 EP1109911A2 (fr) 2001-06-27
EP1109911A4 true EP1109911A4 (fr) 2005-04-27

Family

ID=22271760

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99948076A Withdrawn EP1109911A4 (fr) 1998-09-01 1999-08-31 Genes de staphylococcus aureus et polypeptides associes

Country Status (5)

Country Link
EP (1) EP1109911A4 (fr)
JP (1) JP2002525083A (fr)
AU (1) AU6131999A (fr)
CA (1) CA2341311A1 (fr)
WO (1) WO2000012678A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083924A (en) * 1998-03-12 2000-07-04 Smithkline Beecham Corporation DnaB of staphylococcus aureus
EP1200599A1 (fr) 1999-08-04 2002-05-02 PHARMACIA & UPJOHN COMPANY CRISTALLISATION ET DETERMINATION DE STRUCTURE DE STAPHILOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB)
US6689595B1 (en) 1999-08-04 2004-02-10 Pharmacia & Upjohn Company Crystallization and structure determination of Staphylococcus aureus thymidylate kinase
JP2003517818A (ja) * 1999-08-04 2003-06-03 ファルマシア・アンド・アップジョン・カンパニー スタフィロコッカス・アウレウスのチミジル酸キナーゼの結晶化および構造決定
US6988041B2 (en) 2000-01-31 2006-01-17 Pharmacia & Upjohn Company Crystallization and structure determination of Staphylococcus aureus NAD synthetase
WO2001077365A2 (fr) 2000-04-06 2001-10-18 Pharmacia & Upjohn Company Procedes et materiaux antimicrobiens
US6864080B2 (en) 2000-06-30 2005-03-08 Pharmacia & Upjohn Company Crystallization and structure of Staphylococcus aureus peptide deformylase
WO2004042045A2 (fr) * 2002-11-05 2004-05-21 Affinium Pharmaceuticals, Inc. Structures cristallines de thymidylates kinases bacteriennes
US20090317421A1 (en) * 2006-01-18 2009-12-24 Dominique Missiakas Compositions and methods related to staphylococcal bacterium proteins
WO2009029831A1 (fr) 2007-08-31 2009-03-05 University Of Chicago Procédés et compositions associées pour immuniser contre des maladies et des états staphylococciques des poumons
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
BRPI1010307B1 (pt) 2009-04-03 2021-07-27 University Of Chicago Polipeptídeos variantes de proteína a (spa), composição imunogênica compreendendo os mesmos, vacina, método de produção da referida vacina, bem como uso dos referidos polipeptídeos
CN103037885B (zh) 2010-07-02 2015-08-26 芝加哥大学 与蛋白A(SpA)变体相关的组合物和方法
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916730A2 (fr) * 1997-11-14 1999-05-19 Smithkline Beecham Corporation FabH de Staphylococcus aureus
WO1999046275A1 (fr) * 1998-03-12 1999-09-16 Smithkline Beecham Corporation Dnab de helicase replicative de staphylococcus aureus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10113189A (ja) * 1996-06-06 1998-05-06 Smithkline Beecham Corp 新規 ＲＮａｓｅＰ
DE69735225T2 (de) * 1996-08-28 2006-11-02 Affinium Pharmaceuticals, Inc., Toronto Fab I Enoyl-ACP-Reduktase aus Staphylokokken
US5827689A (en) * 1996-11-13 1998-10-27 Smithkline Beecham Corporation FabD polynucleotides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916730A2 (fr) * 1997-11-14 1999-05-19 Smithkline Beecham Corporation FabH de Staphylococcus aureus
WO1999046275A1 (fr) * 1998-03-12 1999-09-16 Smithkline Beecham Corporation Dnab de helicase replicative de staphylococcus aureus

Also Published As

Publication number Publication date
JP2002525083A (ja) 2002-08-13
WO2000012678A3 (fr) 2000-06-15
WO2000012678A2 (fr) 2000-03-09
CA2341311A1 (fr) 2000-03-09
EP1109911A2 (fr) 2001-06-27
AU6131999A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
EP1233974A4 (fr) Genes et polypeptides du staphylococcus aureus 37
HK1016885A1 (en) Antimicrobial caries-detecting composition
GB2354168B (en) Antimicrobial agents
AU3108399A (en) (staphylococcus aureus) genes and polypeptides
EP1109911A4 (fr) Genes de staphylococcus aureus et polypeptides associes
IL133248A0 (en) Fungicide mixtures
IL130401A0 (en) Antimicrobially active polypeptides
EP0961615A4 (fr) Agent antimicrobien
IL132157A0 (en) Synergetic fungicide composition
GB9820538D0 (en) Anti-microbial drugs
ZA988399B (en) Antimicrobial composition
GB9904924D0 (en) Fungicide use
EP1073677A4 (fr) POLYPEPTIDES ET POLYNUCLEOTIDES pyrH DE STAPHYLOCOCCUS AUREUS
AU5582799A (en) Staphylococcus aureus polypeptides
HUP0002920A3 (en) Therapy for staphylococcus aureus
IL132470A0 (en) Fungicide mixtures
EP1071694A4 (fr) Staphylocoque dore spo0j2: polynucleotide et proteine
EP0970186A4 (fr) SpoOJ2 DE STAPHYLOCOCCUS AUREUS
IL129528A0 (en) Pesticides
GB2385790B (en) Antimicrobial agents
GB9718737D0 (en) Pesticide
GB9904846D0 (en) Pesticide mixtures
PL336128A1 (en) Pesticide
GB9820816D0 (en) Engulfment gene and uses thereof
GB9812660D0 (en) Engulfment gene and uses thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010402

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 20050311

18W Application withdrawn

Effective date: 20050404